규제 업데이트
2026년 9월 11일•1분 읽기
FDA Approves NESHER PHARMS Metoprolol Succinate Extended‑Release ANDA076640
NESHER PHARMS received FDA approval (submission AP) for ANDA076640 covering Metoprolol Succinate extended‑release tablets (200 mg and 100 mg equivalents), though both products are listed as discontinued.
규제 업데이트
2026년 9월 10일•1분 읽기
FDA Grants Approval for Metoprolol Tartrate Injectable (ANDA078085) by Hospira
The FDA has approved Hospira’s Metoprolol Tartrate injectable (ANDA078085), an intravenous prescription drug with a 1 mg/mL strength.
규제 업데이트
2026년 9월 5일•1분 읽기
FDA Approves ANDA078889 for Metoprolol Succinate Extended‑Release Tablets
The FDA has approved ANDA078889 for generic metoprolol succinate extended‑release tablets (100 mg and 200 mg) from several manufacturers.
규제 업데이트
2026년 9월 3일•1분 읽기
FDA Approves Actavis Labs Metoprolol Succinate Extended‑Release Tablets (ANDA 076862)
Actavis Labs FL Inc received FDA approval for its metoprolol succinate extended‑release tablets under ANDA 076862, covering a prescription 50 mg product and a discontinued 25 mg product.
규제 업데이트
2026년 9월 3일•1분 읽기
FDA Approves Lupin ANDA209272 for Metoprolol Succinate ER Tablets
FDA approved Lupin's ANDA209272 for metoprolol succinate extended‑release tablets in four strengths, all currently listed as discontinued.
규제 업데이트
2026년 8월 30일•1분 읽기
FDA Approves NESHER PHARMS Metoprolol Succinate ER Tablet (ANDA077176)
The FDA approved NESHER PHARMS' ANDA077176 for metoprolol succinate extended‑release tablets (50 mg eq). The product is listed as discontinued.
규제 업데이트
2026년 8월 30일•1분 읽기
NESHER PHARMS ANDA077779 for Metoprolol Succinate ER Tablet Approved by FDA
FDA approved ANDA077779 for metoprolol succinate extended‑release tablets from NESHER PHARMS; product listed as discontinued.